• Portrait of Christina Kim
  • Assistant professor

    Max Rady College of Medicine
    Internal Medicine
    L1-101. 409 Tache Avenue
    Winnipeg, Manitoba R2H 2A6
    Assistant professor

    Phone: 204-235-3394
    Fax: 204-237-6048

Research themes

  • Early palliative care
  • Gastrointestinal cancers
  • Pancreatic cancer
  • Real world outcomes
  • Symptom management

Research interests

  • Gastrointestinal cancers
  • Hepatobiliary cancers
  • Hereditary gastrointestinal cancer syndromes
  • Lynch syndrome
  • Palliative care
  • Pancreatic cancer
  • Symptom management


  • Chemotherapy
  • Early palliative care
  • Gastrointestinal cancer
  • Lynch syndrome
  • Medical oncology
  • Pancreatic cancer
  • Real world outcomes
  • Symptom management

Research affiliations

CancerCare Manitoba Research Institute

Research summary

Dr. Kim’s research focuses on gastrointestinal cancer. She has a particular interest in pancreatic cancer, including real world treatment patterns, outcomes and chemotherapy-related toxicity.

Dr. Kim is involved in the development and conduct of investigator-initiated trials. Recent research has focused on symptom burden in pancreatic cancer and the impact of early palliative care on quality of life.

Dr Kim is a clinical lead of the hereditary gastrointestinal cancer clinic and is collaborating with other investigators in development of a registry for Manitoba patients with Lynch Syndrome.


Dr. Christina Ai-Kheng Kim is an assistant professor of internal medicine at the Max Rady College of Medicine at the University of Manitoba. Dr. Kim serves as the research director for the medical oncology residency program committee. She is also a medical oncologist at CancerCare Manitoba.

She was born and raised in Alberta and attended medical school at University of Manitoba. After completion of medical school, she went on to complete an internal medicine residency at the University of British Columbia, followed by a medical oncology subspeciality residency at the University of Alberta.

Dr. Kim was awarded a Canadian Institute of Health Research (CIHR) and Canadian Association of Medical Oncologists (CAMO)-funded fellowship focused on symptom burden and prognostic and predictive markers in pancreatic cancer.

Dr. Kim was recruited as a medical oncologist with CancerCare Manitoba and was appointed assistant professor at the University of Manitoba in 2014.

Dr. Kim is an active member of the gastrointestinal and breast disease site groups at CancerCare Manitoba. She is also one of two clinical leads of the novel Manitoba hereditary gastrointestinal cancer clinic.

Dr. Kim’s clinical practice informs her research, and she is passionate about using clinical research to improve care for patients.



Medical Oncology & Hematology Excellence in Research Award (2019)

Contact us

Internal Medicine
Room GC430, Health Sciences Centre
820 Sherbrook Street
University of Manitoba
Winnipeg, MB R3A 1R9 Canada